Liposomes as delivery systems for nasal vaccination: strategies and outcomes (Q37748791)

22 August 2017

1 reference

title

Liposomes as delivery systems for nasal vaccination: strategies and outcomes (English)

1 reference

22 August 2017

Béatrice Heurtault

1

1 reference

22 August 2017

Benoît Frisch

series ordinal

2

1 reference

22 August 2017

Françoise Pons

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

Expert Opinion on Drug Delivery

22 August 2017

1 reference

22 August 2017

7

1 reference

22 August 2017

7

1 reference

22 August 2017

829-844

1 reference

Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems

22 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Nasal drug delivery: new developments and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Immunization without needles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Nanoparticles for nasal vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Mucosal vaccines: recent progress in understanding the natural barriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

21 January 2018

Liposomal nanomedicines

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Vaccine entrapment in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

CD4 T cells and their role in antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Effect of synthetic lipopeptides formulated in liposomes on the maturation of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Antigen delivery to mucosa-associated lymphoid tissues using liposomes as a carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Design of a liposomal candidate vaccine against Pseudomonas aeruginosa and its evaluation in triggering systemic and lung mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Synthesis of an amphiphilic tetraantennary mannosyl conjugate and incorporation into liposome carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Mucoadhesive liposomes for intranasal immunization with an avian influenza virus vaccine in chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Highly efficient antiviral CD8+ T-cell induction by peptides coupled to the surfaces of liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Effects of alveolar macrophage depletion on liposomal vaccine protection against respiratory syncytial virus (RSV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Evaluation of encapsulated Newcastle disease virus liposomes using various phospholipids administered to improve chicken humoral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Nasal immunization with diphtheria toxoid conjugated-CD52 core peptide induced specific antibody production in genital tract of female mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Influenza hemagglutinin peptides fused to interferon gamma and encapsulated in liposomes protects mice against influenza infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Pathogen recognition and development of particulate vaccines: does size matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Mucosal delivery of vaccine antigens and its advantages in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

The CD40 antigen and its ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Chitosan and its salts for mucosal and transmucosal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Biophysical studies on chitosan-coated liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Chitosan as a novel nasal delivery system for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

The mannose receptor: linking homeostasis and immunity through sugar recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Antigen presentation and T cell stimulation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

Mannose receptor-targeted vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.488687

10.1517/17425247.2010.488687

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference